wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37670334-FE6DE0D6-9A87-4370-B3B5-962B763B41DC
Q37670334-FE6DE0D6-9A87-4370-B3B5-962B763B41DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37670334-FE6DE0D6-9A87-4370-B3B5-962B763B41DC
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch.
P2860
Q37670334-FE6DE0D6-9A87-4370-B3B5-962B763B41DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37670334-FE6DE0D6-9A87-4370-B3B5-962B763B41DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ea1da3f1bdf1a6ce16cf8957a7238d644eb8ea96
P2860
The effectiveness of long-term agalsidase alfa therapy in the treatment of Fabry nephropathy.